From the regression analysis, the KRAS mutation status (mutated or wild) did not influence the likelihood of liver metastasis (P = 0.673); however, when the colon was the primary site, the likelihood of liver metastasis was greater, whereas the likelihood of lung metastasis was higher in the case of primary rectal tumors. Here, KRAS is linked to rectal neoplasm.